Welcome to our dedicated page for Semler Scientific SEC filings (Ticker: SMLR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Semler Scientific, Inc. filings document its common-stock status, material events and public-company reporting history. Recent regulatory records include Form 25 disclosure for removal of the common stock from Nasdaq listing and registration, and Form 15 certification covering termination or suspension of Exchange Act reporting obligations for the class of securities.
The company's 8-K filings cover material agreements, shareholder voting matters, governance items, capital-structure disclosures and operating and financial results. Filing categories also address risk factors and clinical or regulatory matters tied to Semler Scientific's healthcare technology activities, alongside disclosures related to its Bitcoin treasury strategy.
Strive, Inc. posted an investor presentation under Rule 425 regarding its proposed business combination with Semler Scientific, Inc. (SMLR). Strive has filed a Registration Statement on Form S-4 to register Class A common stock to be issued in the transaction, which will include an information statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders. Investors are urged to read these materials when available. Documents can be obtained free of charge from the SEC’s website and the companies’ investor sites. This communication is not an offer or solicitation to buy or sell securities.
Semler Scientific filed an 8-K noting its pending all-stock merger with Strive, Inc. and providing supplemental details on Strive’s recent financing and asset purchases. Strive closed an IPO of 2,000,000 shares of its Variable Rate Series A Perpetual Preferred Stock at $80 per share, generating net proceeds of $149.3 million.
Strive used proceeds to purchase bitcoin and for general corporate purposes. Between October 28 and November 9, 2025, Strive acquired approximately 1,567.2 bitcoin at an average price of $103,315.46 per bitcoin, for a total of $161,912,220 including fees. Following these transactions, Strive holds about 7,525 bitcoin, with a total acquisition cost of $853,218,300 and an average acquisition price of $113,384.18 per bitcoin.
Semler Scientific reported an administrative update on its pending merger with Strive, Inc.. The company filed an 8-K to provide supplemental disclosures about Strive in Exhibit 99.1, tied to the previously announced all-stock acquisition of Semler by Strive under a merger agreement dated September 22, 2025.
The update reiterates that Strive has filed a Form S-4 registering Class A common stock to be issued in the transaction, which will include an information statement/proxy statement/prospectus to be sent to Semler stockholders for voting. The filing emphasizes standard forward‑looking statement cautions and directs investors to SEC and company websites for the S-4 and related materials.
Semler Scientific filed a communication under Rule 425 noting that its Executive Chairman and Director of Bitcoin Strategy retweeted posts about the proposed acquisition of Semler Scientific by Strive, Inc.
Strive has filed a Registration Statement on Form S-4 to register Class A common stock to be issued in the transaction, which will include an information statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive. A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek approval of the proposed transaction.
The companies direct investors to obtain the Registration Statement and related documents from the SEC and company websites. The communication states it is not an offer or solicitation, and includes customary forward‑looking statement cautions.
Semler Scientific announced an administrative update to its planned all-stock acquisition by Strive, Inc.. The company furnished an 8‑K with Exhibit 99.1, providing supplemental disclosures about Strive in connection with the merger agreed on September 22, 2025, subject to the Merger Agreement.
The update notes that Strive has filed a Form S‑4 to register Class A common stock to be issued in the transaction. A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler stockholders to seek approval. The filing includes standard forward‑looking statements cautions and directs investors to the SEC and company websites for the full materials.
Semler Scientific (SMLR) filed an 8-K announcing supplemental disclosures tied to its pending all-stock acquisition by Strive, Inc. The companies entered into a Merger Agreement on September 22, 2025. Semler furnished Exhibit 99.1, which provides additional information regarding Strive and is incorporated by reference.
Strive has filed a Form S-4 to register Class A common stock to be issued in the transaction, which will include an information statement for Strive, a proxy statement for Semler, and a prospectus for Strive. A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler stockholders to seek approval of the proposed transaction. The filing includes standard forward‑looking statement cautions and emphasizes that investors should review the S-4 and related materials for details on the transaction and related risks.
Semler Scientific filed a Rule 425 communication regarding a proposed acquisition by Strive, Inc.. The notice references social posts by Semler’s Director of Bitcoin Strategy and directs investors to official SEC materials for details.
Strive has filed a Form S-4 to register Class A common stock to be issued in the transaction, and a definitive information statement/proxy statement/prospectus will be sent to Semler stockholders to seek approval. The communication emphasizes where to access SEC filings and identifies potential solicitation participants.
It also states this is not an offer or solicitation and includes forward-looking statement cautions, noting that outcomes depend on various risks and uncertainties.
Strive, Inc. filed a Rule 425 communication about its proposed business combination with Semler Scientific (SMLR). The notice includes customary forward‑looking statements and cautions investors about uncertainties.
Strive intends to file a Form S-4 to register Class A common stock to be issued in the transaction, which will include an information statement/proxy statement/prospectus. Semler Scientific stockholders will receive these materials to consider and vote on the deal. The communication states it is not an offer or solicitation to sell securities.
Semler Scientific issued a Rule 425 communication related to the proposed acquisition of Semler Sci by Strive, Inc.. The notice references social media posts by Semler’s Director of Bitcoin Strategy and directs investors to Strive’s filed Form S-4, which registers Class A common stock to be issued in the transaction and will include a combined information statement, proxy statement, and prospectus. A definitive proxy/prospectus will be sent to Semler stockholders to seek approval. The communication identifies potential proxy participants, states it is not an offer or solicitation, and includes forward‑looking statement cautions with references to risk factor filings.
Strive, Inc. filed a communication under Rule 425 regarding its proposed business combination with Semler Scientific (SMLR). The message, reposted on X.com by a Strive board member, includes a forward‑looking statements caution.
Strive intends to file a Form S-4 to register Class A common stock to be issued in the transaction, and an Information Statement/Proxy Statement/Prospectus will be sent to Semler stockholders to seek their approval. Related documents will be available on the SEC’s website and company investor sites. The notice also identifies potential “participants in the solicitation” and states this is not an offer or solicitation to sell securities.